Two National Surveys: Views of Americans and Health Care Providers on Medical Abortion

Will 1999 Be The Year For Mifepristone (RU-486)?
And, An Update on Women’s Other Options for Very Early Abortion

September 16, 1998

Briefing Participants:

Janet Benshoof
Center for Reproductive Law & Policy
120 Wall Street, 18th Floor
New York, NY 10005
Press Contact: Margie Kelly

Jacqueline E. Darroch, PhD
Senior Vice President
The Alan Guttmacher Institute
120 Wall Street
New York, NY 10005

Vanessa Northington Gamble, MD, PhD
Associate Professor
History of Medicine and Family Medicine, and Director
Center for the Study of Race and Ethnicity in Medicine
University of Wisconsin-Madison Medical School

1300 University Avenue
Madison, WI 53706-1532

Elizabeth Newhall, MD
Everywoman’s Health, P.C., and Medical Director
Downtown Women’s Center

401 North Graham, #445
Portland, OR 97227

Felicia H. Stewart, MD
Director of Reproductive Health Programs
Kaiser Family Foundation
2400 Sand Hill Road
Menlo Park, CA 94025
Press Contact: Tina Hoff,
650/854-9400, ext. 210

Carolyn Westhoff, MD, MS
Associate Professor of Clinical Obstetrics and
Gynecology and Public Health
New York Presbyterian Hospital
Columbia Presbyterian Campus
Columbia University

630 West 168th Street, Room 16-80
New York, NY 10032
Press Contact: Karin Eskenazi

Beverly Winikoff, MD
Senior Medical Associate
The Population Council
One Dag Hammarskjold Plaza
New York, NY 10017
Press Contact: Sandra Waldman

Other Resources:

Mifepristone and Methotrexate Research

Mitchell D. Creinin, MD
Director of Family Planning & Family Planning Research
Department of OB/GYN & Reproductive Science
University of Pittsburgh School of Medicine
Magee-Women’s Hospital

300 Halket Street
Pittsburgh, PA 15213-3180

David Grimes, MD
Vice President of Biomedical Affairs
Family Health International
PO Box 13950
Research Triangle Park, NC 27709-3950

Richard Hausknecht, MD
Medical Director
Planned Parenthood of New York City
208 East 72nd Street
New York, NY 10021

Mifepristone Clinical Trials

Lawrence Lader
Abortion Rights Mobilization
51 Fifth Avenue, 10th Floor
New York, NY 10003

Eric Schaff, MD
Associate Professor
Department of Family Medicine
University of Rochester
885 South Avenue
Rochester, NY 14620

Methotrexate Clinical Trials

Michael Burnhill, MD
Vice President of Medical Affairs
Planned Parenthood Federation of America
810 Seventh Avenue
New York, NY 10019-5818
Press Contact: Steve Plever

Manual Vacuum Aspiration Research

Paul Blumenthal, MD
Associate Professor
JHU Department of OB/GYN
Johns Hopkins Bay View Medical Center
4940 Eastern Avenue
Baltimore, MD 21224

Forrest C. Greenslade, PhD
PO Box 100
Carrboro, NC 27510

Patients’ Experiences With Medical Abortion

S. Marie Harvey, DrPH
Pacific Institute for Women’s Health
2999 Overland Avenue, Suite 111
Los Angeles, CA 90064

Provider Training

Jodi Magee
Executive Director
Physicians for Reproductive Choice & Health
1780 Broadway, 10th Floor
New York, NY 10019
Press Contact: Ciara Wilson

Vicki Saporta
Executive Director
National Abortion Federation
1755 Massachusetts, NW, Suite 600
Washington, DC 20036
Press Contact: Stephanie Mueller

Policy And Politics

Elizabeth Cavendish
Legal Director
National Abortion & Reproductive Rights Action League (NARAL)
1156 15th Street, NW, Suite 700
Washington, DC 20005

Marie Bass
Project Director
Reproductive Health Technologies Project
1818 N Street, NW, Suite 450
Washington, DC 20036

Return to top

Will 1999 Be The Year For Mifepristone (RU-486)?

Press Release Fact Sheet Q&A Resource List

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.